The Latest Breaking News from Chemotherapy

The FDA has granted Breakthrough Therapy Designation (BTD) to Daiichi Sankyo (OTC:DSKYF) and AstraZeneca Plc's (NASDAQ:AZN) Enhertu (fam-trastuzumab deruxtecan-nxki) for unresectable or metastatic HER2 low (IHC 1+ or IHC 2+/ISH-negative) breast cancer. The designation covers patients who have received a prior systemic therapy in the metastatic setting or developed disease recurrence during or within six months…

Here's a roundup of top developments in the biotech space over the last 24 hours.

Soap favourite Malandra Burrows has bravely revealed she has been diagnosed with breast cancer, and recently had an op to remove a stage three tumour, with six months of chemotherapy planned.

Doctors discovered a 'ticking time bomb' after Kirsty Axworthy pressed for answers

Kirsty Axworthy was around 12 weeks pregnant when she started to experience symptoms such as high blood pressure, night sweats, exhaustion and migraines

Linda Nolan has detailed the painful side effects of her chemotherapy she has to have each week because of her cancer diagnosis. She explained how she has a new perspective on life since the diagnosis